» Articles » PMID: 36108719

Childhood Exposure to Per- and Polyfluoroalkyl Substances and Neurodevelopment in the CHARGE Case-control Study

Overview
Journal Environ Res
Publisher Elsevier
Date 2022 Sep 15
PMID 36108719
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Per- and polyfluoroalkyl substances (PFAS) are shown to have neurotoxic effects on animals, but epidemiological evidence for associations between childhood PFAS exposure and neurodevelopment is inconclusive. We examined if childhood PFAS concentrations are associated with a diagnosis of autism spectrum disorder (ASD), developmental delay (DD), and other early concerns (OEC) in development.

Methods: We included 551 children 2-5 years old from the CHildhood Autism Risks from Genetics and Environment (CHARGE) case-control study. Children were clinically diagnosed and classified as having ASD, DD, OEC, and typical development (TD). Fourteen PFAS were quantified in child serum samples collected when diagnostic assessments were performed. We used multinomial logistic regression models to investigate the cross-sectional associations of individual PFAS concentrations with neurodevelopmental outcomes and weighted quantile sum (WQS) regression models with repeated holdout validation to investigate the associations with PFAS mixtures.

Results: Childhood perfluorooctanoic acid (PFOA) was associated with increased odds of ASD (odds ratio [OR] per ln ng/mL increase: 1.99, 95% confidence interval [CI]: 1.20, 3.29) and DD (OR: 2.16, 95% CI: 1.21, 3.84) versus TD. Perfluoroheptanoic acid (PFHpA) was associated with increased odds of ASD (OR: 1.61, 95% CI: 1.21, 2.13). However, perfluroundecanoic acid (PFUnDA) was associated with decreased odds of ASD (OR: 0.43, 95% CI: 0.26, 0.69). From mixture analyses, the WQS index was associated with increased odds of ASD (average OR: 1.57, 5th and 95th percentile: 1.16, 2.13). Child's sex and homeownership modified associations of perfluorodecanoic acid (PFDA) with DD and ASD, respectively.

Conclusions: In this case-control study, childhood PFOA, PFHpA, and a PFAS mixture was associated with increased odds of ASD, while PFUnDA was associated with decreased odds of ASD. Because we used concurrent measurements of PFAS, our results do not imply causal relationships and thus need to be interpreted with caution.

Citing Articles

Effects of Early-life PFAS Exposure on Child Neurodevelopment: A Review of the Evidence and Research gaps.

Ames J, Sharma V, Lyall K Curr Environ Health Rep. 2025; 12(1):9.

PMID: 39888511 PMC: 11785707. DOI: 10.1007/s40572-024-00464-5.


Adverse outcome pathway for the neurotoxicity of Per- and polyfluoroalkyl substances: A systematic review.

Li S, Qin S, Zeng H, Chou W, Oudin A, Kanninen K Eco Environ Health. 2024; 3(4):476-493.

PMID: 39605965 PMC: 11599988. DOI: 10.1016/j.eehl.2024.08.002.


Community-Engaged Research and the Use of Open Access ToxVal/ToxRef In Vivo Databases and New Approach Methodologies (NAM) to Address Human Health Risks From Environmental Contaminants.

Silva M, Capps S, London J Birth Defects Res. 2024; 116(9):e2395.

PMID: 39264239 PMC: 11407745. DOI: 10.1002/bdr2.2395.


Prenatal exposure to per- and polyfluoroalkyl substances and child behavioral problems.

Choi J, Oh J, Bennett D, Calafat A, Schmidt R, Shin H Environ Res. 2024; 251(Pt 1):118511.

PMID: 38387490 PMC: 11144101. DOI: 10.1016/j.envres.2024.118511.


Per- and Polyfluoroalkyl Substances (PFAS) in Serum of 2 to 5 year-Old Children: Temporal Trends, Determinants, and Correlations with Maternal PFAS Concentrations.

Oh J, Shin H, Kannan K, Calafat A, Schmidt R, Hertz-Picciotto I Environ Sci Technol. 2024; .

PMID: 38335968 PMC: 10882966. DOI: 10.1021/acs.est.3c08928.


References
1.
Karrman A, Ericson I, van Bavel B, Darnerud P, Aune M, Glynn A . Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect. 2007; 115(2):226-30. PMC: 1831521. DOI: 10.1289/ehp.9491. View

2.
Gump B, Wu Q, Dumas A, Kannan K . Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ Sci Technol. 2011; 45(19):8151-9. PMC: 3184198. DOI: 10.1021/es103712g. View

3.
Schisterman E, Vexler A, Whitcomb B, Liu A . The limitations due to exposure detection limits for regression models. Am J Epidemiol. 2006; 163(4):374-83. PMC: 1408541. DOI: 10.1093/aje/kwj039. View

4.
Braun J . Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol. 2016; 13(3):161-173. PMC: 5322271. DOI: 10.1038/nrendo.2016.186. View

5.
Vuong A, Yolton K, Xie C, Dietrich K, Braun J, Webster G . Childhood exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavioral domains in children at age 8 years. Neurotoxicol Teratol. 2021; 88:107022. PMC: 8578387. DOI: 10.1016/j.ntt.2021.107022. View